[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
January 2013

Visual Function and Optic Pathway Glioma: A Critical Response

Author Affiliations

Author Affiliations: Department of Neurology, Washington University School of Medicine, St Louis, Missouri (Dr Gutmann); Department of Neurology, Children's National Medical Center, Washington, DC (Dr Avery); Department of Neurology, Guy's and St Thomas' Hospitals, London, England (Dr Ferner); and Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois (Dr Listernick).

JAMA Ophthalmol. 2013;131(1):120-124. doi:10.1001/jamaophthalmol.2013.571

The recent letter by Parsa1 regarding visual function and the clinical behavior of optic pathway glioma (OPG) raises several critically significant points worthy of clarification and further discussion. The importance of this debate should not be understated as it is crucial to our approach to the treatment of young children at risk for irreversible vision loss. For clarity, we will address each of Parsa's points systematically.

First Page Preview View Large
First page PDF preview
First page PDF preview